| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | YM-155 | CTRPv2 | pan-cancer | AAC | -0.002 | 1 |
| mRNA | Axitinib | FIMM | pan-cancer | AAC | 0.0077 | 1 |
| mRNA | BRD-K27224038 | CTRPv2 | pan-cancer | AAC | -0.0035 | 1 |
| mRNA | thapsigargin | GDSC1000 | pan-cancer | AAC | 0.0015 | 1 |
| mRNA | ruxolitinib | CTRPv2 | pan-cancer | AAC | -0.0015 | 1 |
| mRNA | CAY10594 | CTRPv2 | pan-cancer | AAC | -0.0016 | 1 |
| mRNA | Nilotinib | FIMM | pan-cancer | AAC | 0.0075 | 1 |
| mRNA | FMK | GDSC1000 | pan-cancer | AAC | -0.0015 | 1 |
| mRNA | ML006 | CTRPv2 | pan-cancer | AAC | -0.0015 | 1 |
| mRNA | FR-180204 | GDSC1000 | pan-cancer | AAC | 0.0012 | 1 |